These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8291228

  • 1. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
    Daibata M, Speck SH, Mulder C, Sairenji T.
    Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
    [Abstract] [Full Text] [Related]

  • 2. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH, Hergenhahn M, Chuang SE, Yeh PY, Wu TC, Gao M, Cheng AL.
    Anticancer Res; 2002 Feb; 22(6C):4065-71. PubMed ID: 12553034
    [Abstract] [Full Text] [Related]

  • 3. Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.
    Nagata Y, Inoue H, Yamada K, Higashiyama H, Mishima K, Kizu Y, Takeda I, Mizuno F, Hayashi Y, Saito I.
    Immunology; 2004 Feb; 111(2):223-9. PubMed ID: 15027908
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H, Cochet C, Hmama Z, Opolon P, Joab I.
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [Abstract] [Full Text] [Related]

  • 5. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.
    Daibata M, Humphreys RE, Takada K, Sairenji T.
    J Immunol; 1990 Jun 15; 144(12):4788-93. PubMed ID: 2161880
    [Abstract] [Full Text] [Related]

  • 6. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L, Kwa D, El-Guindy A, Miller G.
    J Virol; 2002 Jun 15; 76(11):5612-26. PubMed ID: 11991990
    [Abstract] [Full Text] [Related]

  • 7. The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-beta1 mediated reactivation.
    Yin Q, Jupiter K, Flemington EK.
    Virology; 2004 Sep 15; 327(1):134-43. PubMed ID: 15327904
    [Abstract] [Full Text] [Related]

  • 8. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
    Inman GJ, Binné UK, Parker GA, Farrell PJ, Allday MJ.
    J Virol; 2001 Mar 15; 75(5):2400-10. PubMed ID: 11160743
    [Abstract] [Full Text] [Related]

  • 9. 12-O-tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase.
    Gao X, Ikuta K, Tajima M, Sairenji T.
    Virology; 2001 Jul 20; 286(1):91-9. PubMed ID: 11448162
    [Abstract] [Full Text] [Related]

  • 10. Effect of genistein, a tyrosine kinase inhibitor, on latent EBV activation induced by cross-linkage of membrane IgG in Akata B cells.
    Daibata M, Mellinghoff I, Takagi S, Humphreys RE, Sairenji T.
    J Immunol; 1991 Jul 01; 147(1):292-7. PubMed ID: 1711079
    [Abstract] [Full Text] [Related]

  • 11. Anti-Ig-mediated proliferation of human B cells in the absence of protein kinase C.
    Francois DT, Katona IM, June CH, Wahl LM, Feuerstein N, Huang KP, Mond JJ.
    J Immunol; 1988 May 15; 140(10):3338-43. PubMed ID: 3129493
    [Abstract] [Full Text] [Related]

  • 12. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL, Kenney SC.
    Virology; 1998 Nov 10; 251(1):187-97. PubMed ID: 9813214
    [Abstract] [Full Text] [Related]

  • 13. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas.
    Martini M, Capello D, Serraino D, Navarra A, Pierconti F, Cenci T, Gaidano G, Larocca LM.
    J Infect; 2007 Mar 10; 54(3):298-306. PubMed ID: 16784778
    [Abstract] [Full Text] [Related]

  • 14. Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter.
    Liu S, Borras AM, Liu P, Suske G, Speck SH.
    Virology; 1997 Feb 03; 228(1):11-8. PubMed ID: 9024805
    [Abstract] [Full Text] [Related]

  • 15. Lytic cycle gene regulation of Epstein-Barr virus.
    Amon W, Binné UK, Bryant H, Jenkins PJ, Karstegl CE, Farrell PJ.
    J Virol; 2004 Dec 03; 78(24):13460-9. PubMed ID: 15564457
    [Abstract] [Full Text] [Related]

  • 16. Egr-1 expression in surface Ig-mediated B cell activation. Kinetics and association with protein kinase C activation.
    Seyfert VL, McMahon S, Glenn W, Cao XM, Sukhatme VP, Monroe JG.
    J Immunol; 1990 Dec 01; 145(11):3647-53. PubMed ID: 2246508
    [Abstract] [Full Text] [Related]

  • 17. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter.
    Lavens S, Faust EA, Lu F, Jacob M, Leta M, Lieberman PM, Puré E.
    J Virol; 2004 Aug 01; 78(16):8543-51. PubMed ID: 15280463
    [Abstract] [Full Text] [Related]

  • 18. Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus.
    Karimi L, Crawford DH, Speck S, Nicholson LJ.
    J Gen Virol; 1995 Apr 01; 76 ( Pt 4)():759-65. PubMed ID: 9049321
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction.
    Borras AM, Strominger JL, Speck SH.
    J Virol; 1996 Jun 01; 70(6):3894-901. PubMed ID: 8648726
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member.
    Liu S, Liu P, Borras A, Chatila T, Speck SH.
    EMBO J; 1997 Jan 02; 16(1):143-53. PubMed ID: 9009275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.